MESENCHYMAL STROMAL CELLS MAY ENHANCE RESIDUAL HEALTHY HAEMATOPOIESIS IN LOW-RISK MDS PATIENTS

被引：0
|
作者：
Jimenez Solas, T. [1 ]
Muntion Olave, S. [1 ]
Lopez, F. [1 ]
Ortega Herrera, R. [1 ]
Martin Izquierdo, M. [2 ]
Gonzalez Martinez, T. [2 ]
Janusz, K. [3 ]
Ezponda, T. [4 ]
Vilas, A. [4 ]
Alfonso, A. [5 ]
Prosper, F. [5 ]
Molero, A. [6 ]
Valcarcel, D. [7 ]
Sanchez-Guijo, F. [1 ]
Diez-Campelo, M. [1 ]
机构：
[1] Hosp Univ Salamanca, IBSAL, Hematol, Salamanca, Spain
[2] Canc Res Ctr Salamanca, Hematol, Salamanca, Spain
[3] Inst Maimonides Invest Biomed Cordoba, Biol Celular Hematol, Cordoba, Spain
[4] Univ Navarra, IDISNA, Ctr Invest Med Aplicada CIMA, Oncol Hematol, Pamplona, Spain
[5] Univ Navarra, IDISNA, Ctr Invest Med Aplicada CIMA, Hematol, Pamplona, Spain
[6] Univ Autonoma Barcelona UAB, Vall dHebron Hosp, Barcelona, Spain
[7] Vall dHebron Inst Oncol VHIO, Expt Hematol Unit, Barcelona, Spain
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P36
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] Long-term outcome of low-risk MDS patients treated with ESAs: an update of the GFM cohort
    Kelaidi, C.
    Park, S.
    Sapena, R.
    Beyne-Rauzy, O.
    Coiteux, V.
    Vey, N.
    Stamatoullas, A.
    Cheze, S.
    Delaunay, J.
    Ferrant, A.
    Ravoet, C.
    Escoffre-Barbe, M.
    Ades, L.
    Dreyfus, F.
    Fenaux, P.
    LEUKEMIA RESEARCH, 2009, 33 : S122 - S123
  • [42] Erythrocyte Maturation Activator in Low-risk MDS MEDALIST Study: Most of the Patients repeatedly respond to Luspatercept
    Miersch, Claudia
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (06) : 360 - 361
  • [43] TP53 mutations in low-risk MDS patients with isolated del(5q)
    Belickova, M.
    Vesela, J.
    Cermak, J.
    Dostalova, M. M.
    Krejcik, Z.
    Stara, E.
    Zemanova, Z.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2013, 37 : S27 - S28
  • [44] Analysis of Mesenchymal Stromal Cells (MSC) and their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS)
    Geyh, Stefanie
    Cadeddu, Ron Patrick
    Froebel, Julia
    Bruns, Ingmar
    Zohren, Fabian
    Huenerlituerkoglu, Ali-Nuri
    Kobbe, Guido
    Gattermann, Norbert
    Germing, Ulrich
    Haas, Rainer
    Schroeder, Thomas
    BLOOD, 2011, 118 (21) : 1030 - 1030
  • [45] Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients
    Hede, Karyn
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (20) : 1507 - 1509
  • [46] IN VITRO STUDY OF BIOLOGICAL CHARACTERISTICS AND FUNCTIONS OF MESENCHYMAL STEM CELLS IN LOW-RISK MYELODYSPLASTIC SYNDROMES
    Zhang, Y. Z.
    Zhao, D. D.
    Han, X. P.
    Da, W. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 376 - 377
  • [47] MESENCHYMAL STROMAL CELLS ENHANCE HEMATOPOIETIC ENGRAFTMENT IN A MOUSE MODEL OF AUTOLOGOUS TRANSPLANTATION WITH HIGH RISK OF ENGRAFTMENT FAILURE
    Fernandez, M.
    Yanez, R. M.
    Sanchez, R.
    Segovia, J.
    Bueren, J. A.
    Lamana, M.
    CYTOTHERAPY, 2014, 16 (04) : S11 - S12
  • [48] Improved Quality of Life upon Shifting from Darbepoetin to Luspatercept in Patients with Low-Risk Myelodysplastic Syndrome (MDS)
    Almomen, Abdulkareem Mohammed
    Dwaima, Mohammed Eid
    Akkad, Hadeel Bashir
    Owaidah, Tarek M.
    BLOOD, 2023, 142
  • [49] Cytogenetic monitoring of response and karyotype evolution in low-risk MDS patients treated in the LeMon5 study
    Shirneshan, K.
    Platzbecker, U.
    Nolte, F.
    Giagounidis, A.
    Goetze, K.
    Braulke, F.
    Schanz, J.
    Germing, U.
    Haase, D.
    ONKOLOGIE, 2013, 36 : 240 - 240
  • [50] The Different Immunoregulatory Functions on Dendritic Cells between Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Low-Risk or High-Risk Myelodysplastic Syndromes
    Wang, Zhenling
    Tang, Xiaoqiong
    Xu, Wen
    Cao, Zeng
    Sun, Li
    Li, Weiming
    Li, Qiubai
    Zou, Ping
    Zhao, Zhigang
    PLOS ONE, 2013, 8 (03):
12345